FDA expands authorisation of two monoclonal antibodies for treatment and post-exposure prevention… EP News Bureau Dec 6, 2021 Amlanivimab and Etesevimab are monoclonal antibodies that are specifically directed against the spike protein of SARS-CoV-2,…
